PBM Accountability Project and Nearly 50 Stakeholder Organizations Urge Congress to Pass PBM Reforms
Legislation will rein in the profiteering, anticompetitive and anti-consumer practices of PBMs, creating price transparency, making...
top of page
News
Nov 22, 2023
Expert: Working Together, Sharing Information Is Crucial to PBM Reform
In an interview with Pharmacy Times, Cheryl Larson, president and CEO of the Midwest Business Group on Health, discussed the employers’...
Nov 20, 2023
Health Insurers and PBMs Should Brace for a Copay Programs Shift
A federal court decision that struck down expanded use of copay accumulator programs should prompt health insurers and pharmacy benefit...
Nov 16, 2023
Eliminating Anticompetitive PBM Practices Are Free Market Reforms
The current drug pricing market is malfunctioning, an obvious conclusion to anyone who is paying attention. But why? Like much of the...
Nov 16, 2023
House panel passes PBM reforms, ratcheting up chance for passage
WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the...
Nov 15, 2023
Physician entrepreneurs, policy reform can help small businesses navigate rising health care costs
As we approach the end of the year, businesses are facing a 10-year high health care cost hike. While ballooning prices affect all...
Nov 13, 2023
PBM Accountability Project Statement on Introduction of H.R. 6283
U.S. Representatives Mariannette Miller-Meeks (IA-01), Nanette Diaz Barragán (CA-44), Lori Chavez-DeRemer (OR-05), Kathy Manning (NC-06),...
Nov 9, 2023
Senate Finance Committee targets PBM reform in new legislation
In a unanimous 26-0 vote, the Senate Finance Committee passed a comprehensive draft package this week that puts pharmacy benefit manager...
Nov 8, 2023
Senate Finance unanimously advances PBM, mental health bill
The Senate Finance Committee today unanimously advanced a broad legislative package addressing mental health, PBMs and Medicare payment...
Nov 8, 2023
PBMs: When Competition Does Not Benefit Consumers
In recent years, the practices of pharmacy benefit managers (PBMs), initially formed to foster competition in the pharmaceutical market...
Oct 30, 2023
PBMs run media blitz calling out practices of their peers, telling policymakers reforms can cut cost
A group of pharmacy benefit managers (PBMs) has split off from the pack, launching a “six-figure digital media campaign” to make the case...
Oct 17, 2023
CMS' Proposed Drug Pricing Transparency Rule Impacting PBMs And Other PBM Updates
The United States Centers for Medicare & Medicaid Services ("CMS") has proposed new rulemaking (88 FR 34238) to increase drug price...
Oct 14, 2023
How the secrecy of middlemen inflates drug prices
Most Americans believe drugs cost too much and big pharma is to blame. That powerful political sentiment undergirds Medicare’s new...
Oct 3, 2023
Transparency Is The Cure For What Ails American Health Care
A government shutdown has been averted—for now. Congress approved a continuing resolution this weekend that funds the government through...
Oct 3, 2023
Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators
A U.S. judge has struck down a Trump administration rule that allowed health insurers not to count copay assistance offered by drug...
Sep 30, 2023
PBM Accountability Project Statement on Senate Finance Committee PBM Legislation
The Modernizing and Ensuring PBM Accountability Act will bring transparency and accountability to PBM practices that drive up...
Sep 29, 2023
Bipartisan battle over prescription intermediaries heats up
The intermediaries in the prescription drug supply chain are stuck between a rock and a hard place, facing congressional scrutiny and...
Sep 20, 2023
Unravelling the Drug Pricing Blame Game
Prior to the COVID-19 pandemic, few healthcare issues received as much attention and public discourse as prescription drug prices. The...
Sep 19, 2023
PBMs, Big Pharma face off in House hearing
Pharmacy benefit managers emerged as public enemy No. 1 in a congressional hearing Tuesday, underscoring growing bipartisan sympathy for...
Sep 19, 2023
Howard Dean: ‘At last, Congress proposes drug pricing reform that works’
When I worked as a family physician in Vermont, I wrote countless prescriptions to help patients manage their health. If I were still...
Sep 18, 2023
Leading Healthcare Advocates Urge Passage of Protecting Patients Against PBM Abuses Act
Momentum Building for Legislation that Separates PBM Income from the Price of Prescription Medicines Washington, DC – The PBM...
Sep 18, 2023
PBM Accountability Project Statement on House Share the Savings for Seniors Act
Representatives Mariannette Miller-Meeks (IA-01), Deborah Ross (NC-02), Earl L. “Buddy” Carter (GA-01) and Scott Peters (CA-50) have...
Sep 14, 2023
Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs
The U.S. government should monitor the effect that rebates have on Medicare Part D plans and whether these discounts ultimately...
Sep 13, 2023
Medicare patients paid 4 times as much as their drug plans for certain medicines, study finds
Medicare enrollees are paying far more than their prescription-drug plans for dozens of drugs covered under Medicare Part D, according to...
bottom of page